Asia-Pacific’s Next Frontier: Increasing Patient Population and Biotechnology Advancements Accelerate Growth in the Fastest-Growing Region.
A critical factor enabling the success of the biosimilars market is the development of robust, globally harmonized regulatory frameworks. Agencies like the U.S. FDA and the European Medicines Agency (EMA) have spent years establishing rigorous scientific criteria to demonstrate 'biosimilarity'—proving that the biosimilar is highly similar to the reference product with no clinically...
0 Σχόλια 0 Μοιράστηκε 372 Views 0 Προεπισκόπηση